The Persian methamphetamine use in methadone treatment in Iran: implication for prevention and treatment in an upper-middle income country. Issue 1 (December 2015)

• Record Type: Journal Article
• Authors: Alam-mehrjerdi, Zahra; Abdollahi, Mohammad
• Is Part Of: Daru. Volume 23:Issue 1(2015)
• Page Start: 1
• Page End: 3
• Publication Date: 2015-12
• Subjects: Pharmacology -- Periodicals; Drug development -- Periodicals; Pharmaceutical chemistry -- Periodicals; 615.19
• DOI: 10.1186/s40199-015-0134-5
• Languages: English
• ISSNs: 1560-8115

Abstract

Abstract As the most populated Persian Gulf country in West Asia, methamphetamine use in methadone maintenance treatment (MMT) is a new health concern in Iran. Methamphetamine use in MMT can originate in methadone misconceptions or the stimulant effects of methamphetamine use. Several research studies have highlighted the prevalence of methamphetamine use in Iran and conducting further studies on this issue is being developed. Opiate use is treated with MMT. But, there is no effective pharmacological treatment for methamphetamine use and cognitive-behavioral interventions have still remained the best practice. As a psychostimulant drug, methamphetamine use can lead to poor treatment outcomes or even treatment failure among patients in MMT. Therefore, the implementation of methamphetamine education and prevention programs in MMT is required. Prescribing adequate methadone dose and the treatment of comorbidities as well as, doing a series of activities outside treatment is underscored. Methamphetamine use has a chronic nature and methamphetamine treatment is a long-term procedure with a high rate of relapse. Therefore, the implementation of long-term motivational interviewing, teaching necessary skills to prevent relapse and case management is highlighted. A long-term collaboration between treatment teams, patients and their families is suggested to manage methamphetamine use in MMT.